Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study (Q33402456)

26 July 2017

title

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study (English)

1 reference

26 July 2017

1 reference

11

Günther Deuschl

0 references

Johannes K-M Knobloch

Johannes Knobloch

26

0 references

Mario Schiffer

Mario Schiffer

61

0 references

Sebastian Zeissig

59

Sebastian Zeissig

1 reference

26 July 2017

10

Reinhard Dengler

1 reference

26 July 2017

19

Hermann Haller

1 reference

26 July 2017

53

Sebastian Suerbaum

1 reference

26 July 2017

30

Michael P Manns

1 reference

26 July 2017

2

Martin Nitschke

1 reference

26 July 2017

45

Friedhelm Sayk

1 reference

26 July 2017

34

Thomas Münte

1 reference

26 July 2017

49

Stefan Schreiber

1 reference

26 July 2017

1

Jan Menne

1 reference

26 July 2017

5

Jan Beneke

1 reference

26 July 2017

17

Carsten Hafer

1 reference

26 July 2017

56

Karin Weissenborn

1 reference

26 July 2017

48

Harald Schöcklmann

1 reference

26 July 2017

12

Klaus Fellermann

1 reference

26 July 2017

28

Ulrich Kunzendorf

1 reference

Christine Neumann-Grutzeck

26 July 2017

35

Christine Neumann-Grutzeck

1 reference

26 July 2017

Heinz-Jürgen Steinhoff

51

Jürgen Steinhoff

1 reference

26 July 2017

57

Peter Wellhöner

1 reference

26 July 2017

60

Jürgen Büning

1 reference

26 July 2017

Robert Stingele

3

1 reference

26 July 2017

Mariam Abu-Tair

4

1 reference

26 July 2017

Jörn Bramstedt

6

1 reference

26 July 2017

Jan P Bremer

7

1 reference

26 July 2017

Reinhard Brunkhorst

8

1 reference

26 July 2017

Veit Busch

9

1 reference

26 July 2017

Helmut Fickenscher

13

1 reference

26 July 2017

Christoph Gerigk

14

1 reference

26 July 2017

Alexander Goettsche

15

1 reference

26 July 2017

Jobst Greeve

16

1 reference

26 July 2017

Friedrich Hagenmüller

18

1 reference

26 July 2017

Stefan Herget-Rosenthal

20

1 reference

26 July 2017

Bernd Hertenstein

21

1 reference

26 July 2017

Christina Hofmann

22

1 reference

26 July 2017

Melanie Lang

23

1 reference

26 July 2017

Jan T Kielstein

24

1 reference

26 July 2017

Ulrich C Klostermeier

25

1 reference

26 July 2017

Markus Kuehbacher

27

1 reference

26 July 2017

Hendrik Lehnert

29

1 reference

26 July 2017

Tobias F Menne

31

1 reference

26 July 2017

Tobias N Meyer

32

1 reference

26 July 2017

Claus Michael

33

1 reference

26 July 2017

Jens Nuernberger

36

1 reference

26 July 2017

Hermann Pavenstaedt

37

1 reference

26 July 2017

Leyla Ramazan

38

1 reference

26 July 2017

Lutz Renders

39

1 reference

26 July 2017

Jonas Repenthin

40

1 reference

26 July 2017

Wolfgang Ries

41

1 reference

26 July 2017

Axel Rohr

42

1 reference

26 July 2017

Lars Christian Rump

43

1 reference

26 July 2017

Ola Samuelsson

44

1 reference

26 July 2017

Bernhard M W Schmidt

46

1 reference

26 July 2017

Sabine Schnatter

47

1 reference

26 July 2017

Cay U von Seydewitz

50

1 reference

26 July 2017

Sylvia Stracke

52

1 reference

26 July 2017

Andreas van de Loo

54

1 reference

26 July 2017

Martin Vischedyk

55

1 reference

26 July 2017

Monika Wiesner

58

1 reference

26 July 2017

Tanja Kuehbacher

62

1 reference

26 July 2017

EHEC-HUS consortium

63

1 reference

26 July 2017

language of work or name

English

0 references

publication date

19 July 2012

1 reference

26 July 2017

1 reference

26 July 2017

volume

345

1 reference

26 July 2017

page(s)

e4565

1 reference

The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Clinical symptoms, treatment and outcome of EHEC and EHEC-HUS patients treated as in-patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

A German outbreak of haemolytic uraemic syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Eculizumab in severe Shiga-toxin-associated HUS

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Therapeutic apheresis in the treatment of hemolytic uremic syndrome in view of pathophysiological aspects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

28 July 2018

Escherichia coli O157.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Clinical practice. Today's understanding of the haemolytic uraemic syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Monitoring patients in the community with suspected Escherichia coli O157 infection during a large outbreak in Scotland in 1996.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Steroids in the hemolytic uremic syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Open-Source Genomic Analysis of Shiga-Toxin–Producing E. coli O104:H4

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

The 2011 Shiga toxin-producing Escherichia coli O104:H4 German outbreak: a lesson in genomic plasticity.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

Eculizumab for Atypical Hemolytic–Uremic Syndrome

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400392

31 October 2018

Identifiers

DOI

10.1136/BMJ.E4565

1 reference

26 July 2017

1 reference

26 July 2017

1 reference